FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089894954> ?p ?o ?g. }

• W3089894954 abstract "Purpose: Tumor vascular targeting appeared as an appealing approach to fight cancer, though, the results from the clinical trials and drugs in the market were proved otherwise. The promise of anti-angiogenic therapy as the leading tumor vascular targeting strategy was negatively affected with the discovery that tumor vascularization can occur non-angiogenic mechanisms such as co-option. An additional strategy is induction of tumor vascular infarction and ischemia. Methods: Such that we used truncated coagulase (tCoa) coupled to tumor endothelial targeting moieties to produce tCoa-NGR fusion proteins. We showed that tCoa-NGR can bypass coagulation cascade to induce selective vascular thrombosis and infarction of mild and highly proliferative solid tumors in mice. Moreover, combination therapy can be used to improve the potential of cancer vascular targeting modalities. Herein, we report combination of tCoa-NGR with vascular disrupting agent (VDA), vadimezan. Results: Our results show that synergistic work of these two agents can significantly suppress growth of B16-F10 melanoma tumors in C57/BL6 mice. Conclusion: For the first time, we used the simultaneous benefits of two strategies for inducing thrombosis and destruction of tumor vasculature as spatial co-operation. The tCoa-NGR induce thrombosis which reduces blood flow in the peripheral tumor region. And combined with the action of DMXAA, which target inner tumor mass, growth and proliferation of melanoma tumors can be significantly suppressed." @default.
• W3089894954 created "2020-10-08" @default.
• W3089894954 creator A5001534314 @default.
• W3089894954 creator A5010690456 @default.
• W3089894954 creator A5036375422 @default.
• W3089894954 creator A5055996490 @default.
• W3089894954 creator A5061883366 @default.
• W3089894954 creator A5083824515 @default.
• W3089894954 date "2020-04-15" @default.
• W3089894954 modified "2023-09-27" @default.
• W3089894954 title "Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice" @default.
• W3089894954 cites W1782542250 @default.
• W3089894954 cites W1866003637 @default.
• W3089894954 cites W1966726954 @default.
• W3089894954 cites W1980455698 @default.
• W3089894954 cites W1985466440 @default.
• W3089894954 cites W2007551831 @default.
• W3089894954 cites W2012855647 @default.
• W3089894954 cites W2013959979 @default.
• W3089894954 cites W2016263096 @default.
• W3089894954 cites W2034350111 @default.
• W3089894954 cites W2064428124 @default.
• W3089894954 cites W2067593747 @default.
• W3089894954 cites W2082575848 @default.
• W3089894954 cites W2090130591 @default.
• W3089894954 cites W2092258505 @default.
• W3089894954 cites W2092471071 @default.
• W3089894954 cites W2096286209 @default.
• W3089894954 cites W2113962165 @default.
• W3089894954 cites W2140568954 @default.
• W3089894954 cites W2143411828 @default.
• W3089894954 cites W2160912185 @default.
• W3089894954 cites W2162929707 @default.
• W3089894954 cites W2168202400 @default.
• W3089894954 cites W2170315635 @default.
• W3089894954 cites W2170633837 @default.
• W3089894954 cites W2221603109 @default.
• W3089894954 cites W2232266376 @default.
• W3089894954 cites W2301502088 @default.
• W3089894954 cites W2541144692 @default.
• W3089894954 cites W2549713124 @default.
• W3089894954 cites W2564834016 @default.
• W3089894954 cites W2567676221 @default.
• W3089894954 cites W2569530200 @default.
• W3089894954 cites W2587321465 @default.
• W3089894954 cites W2599903719 @default.
• W3089894954 cites W2727665073 @default.
• W3089894954 cites W2743664513 @default.
• W3089894954 cites W2754225065 @default.
• W3089894954 cites W2766548529 @default.
• W3089894954 cites W2781426023 @default.
• W3089894954 cites W2782762980 @default.
• W3089894954 cites W2790708193 @default.
• W3089894954 cites W2799935755 @default.
• W3089894954 cites W2807121348 @default.
• W3089894954 cites W2807823404 @default.
• W3089894954 cites W2887709269 @default.
• W3089894954 cites W2888328083 @default.
• W3089894954 cites W2911973154 @default.
• W3089894954 cites W2945987733 @default.
• W3089894954 cites W2968754779 @default.
• W3089894954 doi "https://doi.org/10.34172/apb.2021.037" @default.
• W3089894954 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8046391" @default.
• W3089894954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33880362" @default.
• W3089894954 hasPublicationYear "2020" @default.
• W3089894954 type Work @default.
• W3089894954 sameAs 3089894954 @default.
• W3089894954 citedByCount "4" @default.
• W3089894954 countsByYear W30898949542022 @default.
• W3089894954 countsByYear W30898949542023 @default.
• W3089894954 crossrefType "journal-article" @default.
• W3089894954 hasAuthorship W3089894954A5001534314 @default.
• W3089894954 hasAuthorship W3089894954A5010690456 @default.
• W3089894954 hasAuthorship W3089894954A5036375422 @default.
• W3089894954 hasAuthorship W3089894954A5055996490 @default.
• W3089894954 hasAuthorship W3089894954A5061883366 @default.
• W3089894954 hasAuthorship W3089894954A5083824515 @default.
• W3089894954 hasBestOaLocation W30898949541 @default.
• W3089894954 hasConcept C126322002 @default.
• W3089894954 hasConcept C203014093 @default.
• W3089894954 hasConcept C2777658100 @default.
• W3089894954 hasConcept C2780394083 @default.
• W3089894954 hasConcept C2780868729 @default.
• W3089894954 hasConcept C502942594 @default.
• W3089894954 hasConcept C71924100 @default.
• W3089894954 hasConcept C98274493 @default.
• W3089894954 hasConceptScore W3089894954C126322002 @default.
• W3089894954 hasConceptScore W3089894954C203014093 @default.
• W3089894954 hasConceptScore W3089894954C2777658100 @default.
• W3089894954 hasConceptScore W3089894954C2780394083 @default.
• W3089894954 hasConceptScore W3089894954C2780868729 @default.
• W3089894954 hasConceptScore W3089894954C502942594 @default.
• W3089894954 hasConceptScore W3089894954C71924100 @default.
• W3089894954 hasConceptScore W3089894954C98274493 @default.
• W3089894954 hasLocation W30898949541 @default.
• W3089894954 hasLocation W30898949542 @default.
• W3089894954 hasOpenAccess W3089894954 @default.
• W3089894954 hasPrimaryLocation W30898949541 @default.
• W3089894954 hasRelatedWork W1995463208 @default.
• W3089894954 hasRelatedWork W2055263348 @default.

• next